Difference between revisions of "S100A10 (TG2)"
(New page: {{Subst:infobox}}) |
m |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | S100A10 |
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | - | + | | S100 calcium-binding protein A10 |
| + | Calpactin-1 light chain | ||
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 16: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Cytosol |
| + | Cornified envelope | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P60903 P60903 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | [[ | + | | [[TG2 reactive residues (S100A10)|Q4]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 30: | Line 29: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | PS''Q''MEHAM |
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=1BT6 1BT6] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1bt6.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1bt6.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 42: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=11258932&dopt=Abstract PMID:11258932] |
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | TG2 catalyze the formation of dimers and multimers |
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:55, 10 March 2015
| S100A10 (TG2) | |
|---|---|
| Substrate peptide name | S100A10 |
| Synonyms | S100 calcium-binding protein A10
Calpactin-1 light chain |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol
Cornified envelope |
| Swissprot ID | P60903 |
| Reactive glutamines | Q4 |
| Reactive lysines | Not determined yet |
| Substrate sequence | PSQMEHAM |
| Structure | 1BT6 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:11258932 |
| Notes | TG2 catalyze the formation of dimers and multimers |
